BioCardia (BCDA) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
BioCardia (BCDA) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.39 Bn | 112.79 Mn | 39.85 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | 17.55 Mn |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | 39.27 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.58 Bn | 251.50 Mn | -33.00 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | 17.37 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 31.95 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 22.25 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.36 Bn | 251.87 Mn | 107.60 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 48.48 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 730,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 730,000.00 |
| Mar 31, 2026 | 1.03 Mn |
| Sep 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 906,000.00 |
| Sep 30, 2024 | 825,000.00 |
| Jun 30, 2024 | 852,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 941,000.00 |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 924,000.00 |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.20 Mn |